Company Performance: Earnings reports, revenue growth, and profitability directly impact investor confidence and stock price.

Sector Trends: The overall health and performance of the biotechnology sector influences investor sentiment towards the company.

Regulatory Landscape: Changes in government regulations related to drug development and approvals can significantly affect the stock.

Clinical Trial Results: Positive or negative results from clinical trials for the company's drug candidates can cause price swings.

Market Conditions: General economic conditions, interest rates, and investor risk appetite impact stock valuations.

Competitor Activity: Actions by competing pharmaceutical companies, such as new drug launches or acquisitions, affect the company's market position.

Investor Sentiment: News, analyst ratings, and social media discussions can influence investor perception and trading activity.

Management Decisions: Strategic decisions made by the company's management team can impact investor confidence and stock value.